1. The Effects of Deregulated Ribosomal Biogenesis in Cancer
   Yiwei Lu et al, 2023, Biomolecules CrossRef
2. Targeting the Ribosome Biogenesis Key Molecule Fibrillarin to Avoid Chemoresistance
   Btissame El Hassouni et al, 2019, Current Medicinal Chemistry CrossRef
3. Transcription elongation mechanisms of RNA polymerases I, II, and III and their therapeutic implications
   Ruth Q. Jacobs et al, 2024, Journal of Biological Chemistry CrossRef
4. Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance
   Amr R. Elhamamsy et al, 2022, Cancer Research CrossRef
5. Quantifying the impact of initial RNA primer length on nucleotide addition by RNA polymerase I
   Stephanie L. Cooper et al, 2024, Biophysical Chemistry CrossRef
6. Natural products inducing nucleolar stress: implications in cancer therapy
   Mi Wu et al, 2022, Anti-Cancer Drugs CrossRef
7. Ribosome biogenesis and ribosomal proteins in cancer stem cells: a new therapeutic prospect
   Priya Samanta et al, 2024, Molecular Biology Reports CrossRef
8. Therapeutic Approaches Targeting Nucleolus in Cancer
   Pietro Carotenuto et al, 2019, Cells CrossRef
9. FKBP51 induces p53‑dependent apoptosis and enhances drug sensitivity of human non‑small‑cell lung cancer cells
   Yu Chen et al, 2020, Experimental and Therapeutic Medicine CrossRef
10. Human pre-60S assembly factors link rRNA transcription to pre-rRNA processing
    Mason A. McCool et al, 2023, RNA CrossRef
11. PAF49: An RNA Polymerase I subunit essential for rDNA transcription and stabilization of PAF53
    Rachel McNamar et al, 2023, Journal of Biological Chemistry CrossRef
12. Effective targeting of RNA polymerase I in treatment‐resistant prostate cancer
    Jin‐Yih Low et al, 2019, The Prostate CrossRef
13. Regulation of p53 in the red-eared slider (Trachemys scripta elegans) in response to salinity stress
    Weihao Li et al, 2019, Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology CrossRef
14. DNA damage response and repair in ovarian cancer: Potential targets for therapeutic strategies
    Mohammad Mirza-Aghazadeh-Attari et al, 2019, DNA Repair CrossRef
15. Loss of RPS27a expression regulates the cell cycle, apoptosis, and proliferation via the RPL11-MDM2-p53 pathway in lung adenocarcinoma cells
    Hongyan Li et al, 2022, Journal of Experimental & Clinical Cancer Research CrossRef
16. Design and synthesis of BMH-21-like quinazolinone derivatives as potential anti-cancer agents
    Fateme Ahmadi Shourkaei et al, 2024, Journal of Molecular Structure CrossRef
17. P53: A key player in diverse cellular processes including nuclear stress and ribosome biogenesis, highlighting potential therapeutic compounds
    Gazmend Temaj et al, 2024, Biochemical Pharmacology CrossRef